Trial intelligence / Profile preview

LXI-15028 vs lansoprazole for duodenal ulcer (China, phase 3)

CTR20211782Phase 3Completed

Sponsor
Roxin Pharmaceutical
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tegoprazan in duodenal ulcer, sponsored by Roxin Pharmaceutical. Started Jul 2021; status: completed.

02

Drugs

tegoprazan
03

Conditions

duodenal ulcer

Beyond the preview

Go deeper on CTR20211782.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20211782.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call